Blog
News, research and explainers on hyperbaric oxygen therapy — drawn from authoritative medical, government and academic sources.
Oxygen Under Pressure Against a Flesh-Eating Infection: A New Review Sifts the HBOT Evidence for Necrotizing Fasciitis
A 2026 narrative review in Frontiers in Cellular and Infection Microbiology maps what is known — and still unproven — about adjunctive hyperbaric oxygen therapy for necrotizing soft tissue infections, where mortality has been stuck at 20 to 40 percent for decades.
How Much Pressure Does the Brain Need? New Rat Study Maps HBOT's Dose-Response for Memory and Plasticity
A study published August 2 in Neuroscience tested hyperbaric oxygen at 1.6, 2.0 and 2.4 ATA in healthy rats and found a distinct pressure sweet spot for hippocampal plasticity and recognition memory — a preclinical finding with direct relevance to the pressure debate in the wellness chamber market.
Wheeling a Ventilated ICU Patient Into a Hyperbaric Chamber: A Staff Survey Maps the Steps That Get Missed
A pilot survey at Poland's National Centre for Hyperbaric Medicine asked nurses and physicians which peri-procedural tasks they had seen skipped when critically ill, mechanically ventilated patients undergo HBOT. The answers informed the first dedicated peri-HBOT safety checklist prototype.
Aurelius Clinic Treats 60 Veterans with HBOT: Inside the Pennsylvania Program Drawing TBI and PTSD Patients from 25 States
Non-profit Aurelius Clinic at Harrisburg University has treated over 60 veterans and special operators using a 19-day accelerated HBOT protocol. The program combines hyperbaric oxygen with transcranial magnetic stimulation and physical training—but FDA has not cleared HBOT for TBI or PTSD.
HBOT for Osteonecrosis of the Femoral Head: New Network Meta-Analysis Ranks Joint-Preserving Therapies
A July 2026 network meta-analysis in Frontiers in Cell and Developmental Biology compares HBOT against core decompression, cell therapy, and shock wave therapy for early-stage hip osteonecrosis.
HBOT Shows Promise for Postoperative Macular Edema Recovery, But FDA Approval Remains Elusive
A new 2026 case study demonstrates accelerated recovery from postoperative macular edema with hyperbaric oxygen therapy, highlighting both the therapeutic potential and regulatory limitations in ophthalmologic applications.
HBOT for Autism: New 2025 Meta-Analysis Shows Promise as FDA Removes Warning Page
A comprehensive 2025 meta-analysis of 17 studies suggests hyperbaric oxygen therapy may improve core autism symptoms, coinciding with FDA's removal of its 'potentially dangerous' warning page for autism treatments.
Korean Study: HBOT Shows Promise for Long COVID Fatigue and Brain Fog
A prospective observational study from South Korea finds that 73% of Long COVID patients recovered from fatigue after 10 sessions of hyperbaric oxygen therapy, with measurable improvements in verbal and working memory.
FDA Issues Urgent Safety Letter on HBOT Devices After Reports of Fires, Injuries, and Deaths
The FDA's August 2025 letter to health care providers warns of serious injuries and deaths linked to hyperbaric oxygen therapy devices, emphasizing fire risks, proper training, and strict adherence to manufacturer protocols.
The HOBIT Trial: Inside the NIH-Funded Study That Could Change Severe Brain Injury Treatment
A landmark NIH-funded trial testing hyperbaric oxygen for severe traumatic brain injury is nearing completion. With 160 of 200 patients enrolled, researchers are closer than ever to answering whether pressurized oxygen can improve outcomes for the most devastating brain injuries.
Buying a Hyperbaric Chamber for Home Use: A Clinician's Checklist
Home hyperbaric chambers have moved from fringe to mainstream. A practical, safety-first checklist for evaluating pressure ratings, certifications, oxygen handling, installation, and vendor support before buying a chamber for your home.
Hard-Shell vs Soft-Shell Hyperbaric Chambers: A Clinical Perspective
The hard-shell vs soft-shell decision is really a pressure decision. What the clinical literature's 2.0 ATA protocols mean for chamber choice, where mild 1.3–1.5 ATA systems genuinely fit, and how to match the machine to the use case.
How Much Does a Hyperbaric Chamber Cost? What Clinics Actually Pay
Hyperbaric chamber prices span $5,000 to over $800,000 depending on pressure rating, shell construction, and capacity. A practical breakdown of what clinics and home buyers actually pay — and the ownership costs the sticker price hides.
HBOT for Filler-Induced Vascular Occlusion: What the Evidence Actually Shows
A 2026 scoping review mapped every published report of hyperbaric oxygen used for dermal filler vascular occlusion and found only case-level evidence. HBOT is off-label here — not FDA-cleared, not a UHMS indication, and never a substitute for hyaluronidase.
Hyperbaric Oxygen Shows Early Promise in Drug-Refractory Ulcerative Colitis
A Dutch phase 2a pilot found adjunctive hyperbaric oxygen therapy improved clinical and endoscopic outcomes in ulcerative colitis that had failed multiple drugs. The trial was small and unblinded, and HBOT is not FDA-cleared for colitis.
Gas Gangrene and HBOT: How Hyperbaric Oxygen Saves Lives in Clostridial Myonecrosis
Gas gangrene is a surgical emergency with mortality rates exceeding 25% without proper treatment. Hyperbaric oxygen therapy is FDA-cleared and UHMS-recommended as part of the standard triple therapy for this devastating infection.
HBOT for Crush Injury and Compartment Syndrome: An Underused FDA-Cleared Lifesaver
Crush injury and compartment syndrome are time-critical emergencies where hyperbaric oxygen therapy is FDA-cleared. New research explores optimal timing, pressure protocols, and outcomes in acute traumatic ischemia.
HBOT for Diabetic Foot Ulcers: What GRADE Evidence Says in 2026
New 2026 reviews apply GRADE methodology to hyperbaric oxygen therapy for diabetic foot ulcers, finding moderate-certainty evidence for healing benefits while highlighting gaps in long-term data and patient selection.
HBOT for Compromised Skin Grafts and Flaps: How Oxygen Pressure Saves Surgical Outcomes
New 2026 evidence confirms hyperbaric oxygen therapy improves graft survival rates when vascular compromise threatens reconstructive surgery outcomes.
Hyperbaric Oxygen Plus Polarized Light Therapy Shows Promise for Neuropathic Foot Ulcers: New RCT
A randomized controlled trial from Egypt demonstrates that combining hyperbaric oxygen therapy with polarized light therapy significantly improves healing in neuropathic foot ulcers compared to standard care alone.
Cardiac Extracellular Vesicle Proteomics Reveals How HBOT Reverses Carbon Monoxide–Induced Heart Damage
A new Taiwanese study uses cardiac extracellular vesicle proteomics to uncover the molecular mechanisms by which hyperbaric oxygen therapy protects the heart after carbon monoxide poisoning.
HBOT vs. Mild HBOT: Why Pressure and Oxygen Levels Matter
A new 2026 narrative review clarifies the critical differences between clinical hyperbaric oxygen therapy and mild hyperbaric oxygen therapy—differences that wellness marketing often obscures.
HBOT Speeds Recovery from Exercise-Induced Muscle Injury, Meta-Analysis Finds
A 2026 systematic review and meta-analysis of 10 RCTs shows hyperbaric oxygen therapy significantly accelerates recovery from exercise-induced muscle injury, though effects on muscle soreness are mixed.
Community-Delivered HBOT for Long COVID: A 2026 Pilot Study Shows Promise
A new UK pilot study finds community-based hyperbaric oxygen therapy improved fatigue, breathlessness, and quality of life in Long COVID patients—while highlighting the need for larger controlled trials.
When Bone Infections Refuse to Heal: HBOT as an FDA-Cleared Lifeline
Chronic refractory osteomyelitis affects over 50,000 Americans annually. Learn why HBOT is an FDA-cleared adjunctive therapy and what the evidence shows about cure rates, mechanisms, and long-term outcomes.
When Spine Surgery Causes Blindness: A 2026 Case Report on HBOT for Perioperative Vision Loss
A rare but devastating complication of prone spinal surgery—central retinal artery occlusion—left a patient with hand-motion vision. Delayed hyperbaric oxygen therapy restored functional sight, illustrating both the risks of positioning and the therapeutic window for this FDA-cleared indication.
HBOT for Thermal Burns: What a New 2026 Systematic Review Reveals
A comprehensive 2026 systematic review examines hyperbaric oxygen therapy as an adjunct for thermal burn care, finding promise for reduced surgeries and faster healing while highlighting key evidence gaps.
What Can Go Wrong: A Clinical Guide to HBOT Side Effects
A new 2026 UHMS Journal review quantifies the risks of hyperbaric oxygen therapy—from barotrauma to oxygen toxicity—and explains how proper protocols keep complications rare.
Hyperbaric Oxygen Therapy for Radiation-Induced Brain Necrosis: New Review Shows 60% Response Rate
A June 2026 Frontiers in Oncology review synthesizes evidence on HBOT for radiation necrosis, reporting symptom stabilization or improvement in approximately 60% of patients.
Hyperbaric Oxygen Therapy Shows Promise for Treatment-Refractory Colitis in Early Trial
A phase 2a pilot study from the Netherlands suggests HBOT may help stabilize biologic-refractory ulcerative colitis, offering a potential new avenue when standard therapies fail.
The HBOT Boom in Med Spas and Celebrity Homes Has Safety Experts Warning of 'Absolute Anarchy'
As hyperbaric oxygen therapy explodes in popularity at med spas and private residences, safety experts warn of unregulated expansion, fire risks, and a tragic Michigan chamber explosion that killed a 5-year-old boy.
Can Hyperbaric Oxygen Therapy Ease Fibromyalgia Pain? Evidence and FDA Reality
Patients with fibromyalgia report reduced pain after HBOT, but the FDA has not cleared the therapy for this use. A look at the emerging research and the regulatory caution that surrounds it.
Hyperbaric Oxygen Therapy Shows Promise for Post-Stroke Depression in New Randomized Trial
A 2026 sham-controlled study reports significant reductions in depression scores among stroke survivors treated with HBOT, alongside biomarker changes suggesting neuroplasticity. Here's what the evidence shows—and why FDA clearance remains distant.
Neurological and Cardiac Determinants Drive HBOT Selection in Carbon Monoxide Poisoning: New 2026 Study
A retrospective study of 272 patients reveals that neurological impairment and cardiac involvement—not just carboxyhemoglobin levels—are the primary factors guiding hyperbaric oxygen therapy decisions in carbon monoxide poisoning.
Hyperbaric Oxygen for Long COVID: Promising Israeli Results Meet Skeptical Swedish Data
Two recent randomized trials paint different pictures of HBOT for long COVID. We break down the Shamir Medical Center study showing lasting cognitive gains versus the Swedish HOT-LoCO trial that found no benefit over sham—and what the FDA says about off-label use.
When Silence Strikes Suddenly: How HBOT Became a Lifeline for Sudden Hearing Loss
Idiopathic sudden sensorineural hearing loss is one of the few neurological emergencies where hyperbaric oxygen therapy holds FDA clearance. A look at the evidence, treatment windows, and why timing matters.
New Mouse Study Suggests HBOT May Slow Alzheimer's Pathology — But FDA Has Not Approved It
A February 2026 study in Experimental Neurology shows hyperbaric oxygen reduced amyloid plaques and improved cognition in Alzheimer's mice. Human trials show promise, yet the FDA maintains HBOT is not approved for dementia treatment.
Do Hyperbaric Chambers Actually Help Athletes Recover? A 2025 Evidence Review
A new narrative review in the Undersea and Hyperbaric Medicine Journal examines the evidence for HBOT in athletic recovery—finding promise for soft-tissue injuries but limited data for performance enhancement.
HBOT Shows Promise for ME/CFS Symptoms in New German Study—With a Caveat
A prospective cohort study from Berlin's Charité hospital finds hyperbaric oxygen therapy improved physical function and modulated thalamic connectivity in ME/CFS patients, but FDA clearance for this indication remains absent.
NHS England to Slash Hyperbaric Chamber Network: A Looming Access Crisis
NHS England plans to cut hyperbaric oxygen therapy centers from eight to three, raising alarms about emergency access for divers and patients with approved indications.
FDA Reiterates Warning on Unproven Hyperbaric Oxygen Uses as Clinical Research Expands
Federal regulators caution that most wellness and longevity claims for hyperbaric oxygen therapy remain uncleared, even as new trials probe its role in brain injury and chronic wounds.
HBOT for Veterans: What the VA, Pentagon, and GAO Actually Concluded About TBI and PTSD
Hyperbaric oxygen is heavily marketed to veterans for brain injury and PTSD. The federal research record — large sham-controlled trials, the VA/DoD guideline, and a GAO review — tells a far more cautious story.
Hyperbaric Oxygen for Diabetic Foot Ulcers: What Cochrane and Medicare Actually Say
The highest-quality evidence review and U.S. payer policy agree on a cautious middle ground: a real short-term healing benefit that fades by one year, built on weak trials — and Medicare coverage tightly gated to advanced wounds that have failed standard care.
Inside the HBOT Research Frontier: Long COVID, Brain Injury, and What the Trials Actually Show
Hyperbaric oxygen is moving from anecdote toward evidence on its hardest targets — the post-COVID brain and traumatic brain injury. A sham-controlled trial reported real cognitive gains, and large new randomized studies are now enrolling.
Can HBOT Turn Back the Clock? The Telomere Studies, and Where the FDA Draws the Line
Hyperbaric oxygen is increasingly sold as a longevity 'biohack.' Real peer-reviewed studies report longer telomeres and better cognition in older adults — but the FDA has never cleared it for aging, and a 2025 safety letter followed fatal chamber fires.